ClinicalTrialsFinder

TNBC - Triple-Negative Breast Cancer Clinical Trials in Washington D.C., District of Columbia

2 recruitingWashington D.C., District of Columbia

Showing 1–2 of 2 trials

Recruiting
Phase 2

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Breast CancerBreast NeoplasmsHER2-negative Breast Cancer+6 more
QuantumLeap Healthcare Collaborative5,000 enrolled42 locationsNCT01042379
Recruiting

CtDNA Based MRD Testing for NAC Monitoring in TNBC

TNBC - Triple-Negative Breast CancerMinimal Residual Disease
Personalis Inc.422 enrolled14 locationsNCT06230185